Shopping Cart
- Remove All
Your shopping cart is currently empty
Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 mg | Inquiry | Backorder | |
| 100 mg | Inquiry | Backorder |
| Description | Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets. |
| Targets&IC50 | GT3a:0.90±0.2 nM (Ki), GT2b:0.15±0.06 nM (Ki), GT1b:0.01±<0.01 nM (Ki), GT2a:0.08±0.02 nM (Ki), GT1a:0.01±0.01 nM (Ki) |
| Synonyms | MK-5172 potassium salt, MK 5172 potassium, Grazoprevir potassium |
| Molecular Weight | 805 |
| Formula | C38H49KN6O9S |
| Cas No. | 1206524-86-8 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.